English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Upon review, a number of discrepancies were found between the study described in the article and the details provided for the registered clinical trial, ChiCTR-TRC-11001791 (www. chictr.org.cn/hvshowproject.aspx?id=1867). For example, the CTR number had been wrongly ascribed in the methods section of the published article as an ethics approval number for the Medical Ethics Committee of Peking University People’s Hospital. The participants described in the published article ranged from 18–72 years of age, whereas the participants described in the registered clinical trial ranged from 60–120 years of age. The study outlined in the clinical trial was described as investigating cognitive dysfunction in elderly patients, however the present study was clearly described as investigating postoperative pain in patients as young as 18 years old. There were also 100 participants described in the registered clinical trial study (50 in each intervention group), while only 72 participants were described in the present article and none were ascribed to any specific intervention group.

journal of pain research

&lt;p&gt;Population Pharmacokinetic Modeling Of Flurbiprofen, The Active Metabolite Of Flurbiprofen Axetil, In Chinese Patients With Postoperative Pain [Expression Of Concern]&lt;/p&gt;